YASUDA ENTERPRISE DEVELOPMENT
The organisation provide supporting of international business development, strong expertise of strategic alliance, syndicating professional investors and strong corporate partners. They invest in: Growing companies of all stages with potential IPO and M&A. Specializing in innovative & state-of-the-art technology companies in Information Technology industries. Focusing on emerging companies having the cutting edge technologies in Medical Device and Bio Technology area. Targeting companies with great potential for penetration in the global market.
YASUDA ENTERPRISE DEVELOPMENT
Social Links:
Industry:
Biotechnology Semiconductor Venture Capital
Founded:
1999-01-01
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2015-10-28 | Universal View | Yasuda Enterprise Development investment in Venture Round - Universal View | 400 M JPY |
2013-12-13 | Universal View | Yasuda Enterprise Development investment in Venture Round - Universal View | 300 M JPY |
2012-08-15 | Ubiquisys | Yasuda Enterprise Development investment in Venture Round - Ubiquisys | 19 M USD |
2011-10-18 | Topica Pharmaceuticals | Yasuda Enterprise Development investment in Series B - Topica Pharmaceuticals | 27 M USD |
2011-03-21 | Synageva BioPharma | Yasuda Enterprise Development investment in Venture Round - Synageva BioPharma | 25 M USD |
2010-07-12 | Ubiquisys | Yasuda Enterprise Development investment in Venture Round - Ubiquisys | 9 M USD |
2010-01-28 | SymBio Pharmaceuticals | Yasuda Enterprise Development investment in Corporate Round - SymBio Pharmaceuticals | 114.96 M JPY |
2009-12-14 | Streetmedia | Yasuda Enterprise Development investment in Seed Round - Streetmedia | 50 M JPY |
2009-12-11 | SymBio Pharmaceuticals | Yasuda Enterprise Development investment in Venture Round - SymBio Pharmaceuticals | 2.2 B JPY |
2009-10-22 | Synageva BioPharma | Yasuda Enterprise Development investment in Series F - Synageva BioPharma | 12 M USD |